Home Thomson StreetEvents

Iterum Therapeutics PLC Q4 2024 Earnings Call Transcript

Published Feb 07, 2025

6 pages (3252 words) — Published Feb 07, 2025

Price US$ 54.00 | Buy this Report Now

About This Report

Abstract:

Edited Transcript of ITRM.OQ earnings conference call or presentation 7-Feb-25 1:30pm GMT

Brief Excerpt:

...Operator Hello, everyone, and welcome to the Iterum Therapeutics PLC Fourth-Quarter and Full Year 2024 Financial Results. My name is Ezra, and I will be your coordinator today. (Operator Instructions) I will now hand you over to Louise Barrett, Senior Vice President, Legal Affairs, to begin. Louise, please go ahead. Louise Barrett ...

Report Type:

Transcript

Source:

Thomson StreetEvents

Company:

Iterum Therapeutics PLC

Ticker

ITRM.OQ

Time

1:30pm GMT

Format:

PDF

The following is excerpted from the question-and-answer section of the transcript. (Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session) Question: Thomas Yip - H.C. Wainwright & Co., LLC - Analyst : Hello. Good morning, everyone. This is Thomas asking a couple of questions for Ed. Thank you so much for taking questions. Perhaps first question, I wonder if you can discuss any feedback or details on your ongoing discussions with potential partners? And also, if you can discuss what type of entities are you having discussions with such as pharma companies or financial organizations? What type of partners are you seeking out currently? Question: Thomas Yip - H.C. Wainwright & Co., LLC - Analyst : Understood. And then on the other side, you mentioned that there are four commercial preparations are ongoing. I wonder if you can highlight some activities on that front. Question: Thomas Yip - H.C. Wainwright & Co., LLC - Analyst : Understood. That's all the questions left for now. Thank you so much for taking the questions and looking forward to progress in the ongoing discussions.

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Thomas Yip - H.C. Wainwright & Co., LLC - Analyst : Hello. Good morning, everyone. This is Thomas asking a couple of questions for Ed. Thank you so much for taking questions. Perhaps first question, I wonder if you can discuss any feedback or details on your ongoing discussions with potential partners? And also, if you can discuss what type of entities are you having discussions with such as pharma companies or financial organizations? What type of partners are you seeking out currently?

Question: Thomas Yip - H.C. Wainwright & Co., LLC - Analyst : Understood. And then on the other side, you mentioned that there are four commercial preparations are ongoing. I wonder if you can highlight some activities on that front.

Question: Thomas Yip - H.C. Wainwright & Co., LLC - Analyst : Understood. That's all the questions left for now. Thank you so much for taking the questions and looking forward to progress in the ongoing discussions.

Iterum Therapeutics PLC Q1 2025 Earnings Call Transcript – 2025-05-13 – US$ 106.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 13-May-25 12:30pm GMT

Iterum Therapeutics PLC Q3 2024 Earnings Call Transcript – 2024-11-14 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 14-Nov-24 1:30pm GMT

Iterum Therapeutics PLC Conference Call Transcript – 2024-10-28 – US$ 54.00 – Edited Transcript of ITRM.OQ conference call or presentation 28-Oct-24 12:30pm GMT

Iterum Therapeutics PLC Q4 2023 Earnings Call Transcript – 2024-03-28 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 28-Mar-24 12:30pm GMT

Iterum Therapeutics PLC Q3 2023 Earnings Call Transcript – 2023-11-14 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 14-Nov-23 1:30pm GMT

Iterum Therapeutics PLC Q2 2023 Earnings Call Transcript – 2023-08-11 – US$ 54.00 – Edited Transcript of ITRM.OQ earnings conference call or presentation 11-Aug-23 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author

Cite this Report


MLA:	Thomson StreetEvents. "Iterum Therapeutics PLC Q4 2024 Earnings Call Transcript" Feb 07, 2025. Alacra Store. May 23, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2024-Iterum-Therapeutics-PLC-Earnings-Call-T16244313>

APA:	Thomson StreetEvents. (2025). Iterum Therapeutics PLC Q4 2024 Earnings Call Transcript Feb 07, 2025. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2024-Iterum-Therapeutics-PLC-Earnings-Call-T16244313>

US$ 54.00

$ £ €

Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

Example Report

Click to View Sample Report

More Research

Search all our Credit Research from one place.

Iterum Therapeutics PLC Q4 2024 Earnings Call Transcript

About This Report

Table Of Contents

More from Thomson StreetEvents

About the Author

Cite this Report